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Spinal muscular atrophy (SMA) is a rare lower motor neurone disease in which anesthetic management is often 
difficult as a result of muscle weakness, hypersensitivity to non-depolarizing neuromuscular blocking agent, and 
succinylcholine induced hyperkalemia. We describe a 50-year-old patient with type IV SMA for synovectomy. We 
decided to use an epidural technique to avoid muscle relaxants and tracheal intubation. After operation, there was 
no exacerbation of neurologic signs and symptoms. (Korean J Anesthesiol 2010; 59: S65-S68)
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    Spinal muscular atrophy (SMA) is a rare lower motor neuron 
disease that occurrs due to degeneration of anterior horn 
cell. SMA patients require particular attention for narcosis 
management since there is a possibility for mechanical 
ventilation when a delayed recovery of spontaneous respiration 
occurs after an operation using general anesthesia as a sensitive 
reaction against skeletal muscle relaxants and weakened 
respiratory root [1]. Accordingly, regional anesthesia can be 
an option as an alternative of general anesthesia for lower 
extremity surgery. 
    The authors successfully conducted narcosis management for 
epidural anesthesia for patients with type IV spinal muscular 
atrophy without worsening the neurological symptoms or 
creating respiratory complications. Since there has not been any 
previous domestic report about regional anesthesia for patients 
with spinal muscular atrophy, this study reports the case. 
Case Report 
    A 50-year-old male patient visited the hospital to undergo 
synovectomy for left knee ostarthritis and tenosynovitis. The 
patient had suffered difficulties in walking from weakening of 
both lower limb muscles since 25 years ago, and recently the 
symptom of weakness of lower limb muscles became more 
serious and dyspnea at the level of ATS (American Thoracic 
Society) Dyspnea Grade I had occurred due to the weakening 
of the respiratory root. A molecular genetics examination 
conducted at another hospital discovered a deficit of the SMN1 
gene, and considering the time of onset and clinical conditions, 
the patient was diagnosed with type IV spinal muscular atrophy. S66 www.ekja.org
Epidural anesthesia for the patient with type IV spinal muscular atrophy Vol. 59, Suppl, December 2010
The patient stood 168 cm and weighed 63 kg, and there were no 
special opinions from ECG and simple radioactive examination 
before operation. Arterial blood gas analysis (ABGA) showed 
pH 7.435, PaO2 74.6 mmHg, PaCO2 36.9 mmHg, and HCO3- 24.2 
mmHg. The patient was under drug treatment for hypertension. 
Administration before anesthesia was not conducted and vital 
signs examined after going into the operating room were blood 
pressure: 160/100 mmHg; respiration rate per minute: 20 times; 
ECG: normal sinus rhythm; and pulse oxymetry: 98%. From 
a manual muscle test before operation, both legs were at the 
4th stage. At the genupectoral position, the epidural space was 
identified by loss of resistance technique using an 18 G Tuohy 
insertion needle in between the L2-L3 lumbar, and after a test 
dose injection of 1.5% lidocaine 3 ml containing 1 : 200,000 
epinephrine, no increase of heart rate or spinal anesthesia 
symptom was detected. After injecting 0.75% ropivacaine 12 ml, 
a catheter was placed and maintained. To measure the level of 
motor block by time after anesthesia, a modified Bromage scale 
(0: One can stretch and raise his/her leg; 1: One cannot raise 
his/her leg and cannot bend his/her knee; 2: One cannot his/
her knee but can bend his/her ankle; 3: One cannot bend his/
her ankle) was applied. 
    The level of modified Bromage scale before anesthesia was 1, 
and 20 minutes after injecting ropivacaine, the level of modified 
Bromage scale was 3. The sensory nerves were blocked by 
T8 segment on pinprick examination. Vital signs during 
operation were blood pressure: 120-140/60-80 mmHg and 
pulse rate per minute: stable at 70-80 times. A Venti
Ⓡ mask 
with 35% of oxygen fraction in inspired air was used, and an 
ETCO2 capnometer was placed under the nose of the patient 
to monitor the end-tidal CO2. ETCO2 was stable at 35 mmHg 
and the pulse oxymetry was 100%. Due to the risk of aspiration 
of saliva or bronchial secretion during operation, sedation was 
not operated. The surgery was operated for an hour, and the 
epidural catheter was removed after operation. After finishing 
the operation, the level of modified Bromage scale was 3 and 
the sensory nerve block was decreased up to the T9 segment. 
Three hours after the operation, the level of modified Bromage 
scale was dropped to 2 and the sensory nerve block to the T11 
segment; 5 hours after the operation, the stage of modified 
Bromage scale was 1, and the sensory nerve was declined to 
the L1 segment. Since the patient did not show adverse effects 
including vomiting, nausea, and dizziness in the recovery room, 
he was moved to a patient room. Twelve hours after finishing 
the operation, both the level of the modified Bromage scale and 
sensory nerve were recovered to the condition before operation, 
and also for the manual muscle test, both legs were maintained 
at the 4th stage. A physical exam conducted 24 hours after 
finishing surgery did not show special opinions. The patient 
recovered smoothly without complications and left the hospital 
2 days after the operation. 
Discussion 
    Spinal muscular atrophy is a rare lower motor neuron disease, 
which does not accompany sensory loss, and is an autosomal 
recessive disorder that occurrs due to a genetic deficit of the 
survival motor neuron (SMN) existing in chromosome 5. The 
incidence rate is 1/10,000 while it occurs as an autosomal 
recessive within 95-98% and an autosomal dominant within 
2-5% [1]. The disease incurs motor nerve regression of the 
brain stem and anterior horn, leading to limb weakness and 
atrophy of the torso and proximal biceps tendon, paradoxical 
breathing related with bulbar paralysis, repeated upper 
respiratory infection, and severe kyphoscoliosis. Restrictive lung 
disease often occurs due to skeleton malformations, including 
kyphoscoliosis or contracture, and the patient cannot stand or 
walk according to his/her own will and sometimes rely on an 
artificial respirator [2]. 
    For diagnosis of spinal muscular atrophy, clinical symptoms 
are most critical, and for differential diagnosis, serum enzymes 
measurements including CK, LDH, aldolase, aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), elec-
tromyogram test, and muscle biopsy examination are useful. 
As the SMN gene and neuronal apoptosis inhibitory protein 
(NAPI) gene were discovered by molecular genetics research, 
a molecular genetics diagnosis became available [3]. Spinal 
muscular atrophy can be classified by a number of criteria 
including clinical conditions, genotype, and onset timing. 
Among them, the ISMAC (International SMA Consortium) 
system, which classifies the disease by onset timing, is applied 
the most widely. It divides the types of disease by type I: within 
6 months after birth; type II: between 6 and 18 months; type 
III: after 18 month from birth; and type IV: for adults in the 
middle of one’s 30s. Type I spinal muscular disease (Werdnig-
Hoffman disease) occurs within 6 months from the date of 
birth, and most of the patients die within 18 months due to 
serious muscle weakness and myelencephalon hypofunction. 
Type II spinal muscular atrophy, the most common type, occurs 
between 6 and 18 months and most of the patients die within 
2 years. The symptoms are milder hypotonus and fasciculation 
than type I. Type III spinal muscular atrophy (Kugelberg-
Welander syndrome) occurs 18 months after the birth, and its 
characteristic is that symptoms are mild and proceed slowly. 
Most patients can have a normal lifestyle [1]. For adulthood 
disease, Pearn classified the type IV spinal muscular atrophy, 
and clinical conditions that mostly occur in the middle of a 
patient’s 30s with mild symptoms, as type III [4]. Recovery 
after general anesthesia of patients with spinal muscular 
atrophy can be delayed because of restrictive lung disease S67 www.ekja.org
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from malformation and respiratory muscle weakness. Also, 
the most important thing in conducting general anesthesia 
for patients with spinal muscular atrophy is the use of skeletal 
muscle relaxants. Administration of skeletal muscle relaxants 
for patients with spinal muscular atrophy extends muscle 
relaxation and delays recovery, so special attention should be 
paid to their use. 
    Since acetylcholine is decreased from declined choline 
acetyltransferase from regression and atrophy of anterior horn 
cell, the sensitivity toward the depolarizing skeleton muscle 
relaxants increases and, at the same time, there is the possibility 
of respiratory root weakness and aspiration due to muscle 
regression. Against this backdrop, special attention should be 
paid to the use of skeleton muscle relaxants, dose setting, and 
reverse of the nerve block [5]. Also, succinylcholine is a taboo 
for the risk of extreme hyperkalemia and rhabdomyolysis. 
Accordingly, regional anesthesia can be an alternative to 
general anesthesia for bupivacaine. However, some worry that 
regional anesthesia for patients with spinal muscular atrophy 
can cause neurologic deficit, including worsening of limb motor 
nerve weakness. Upton and McComas [6] insist that if patients 
who have already suffered neurological malfunction are 
exposed to secondary damages such as injuries from needles 
or catheters, ischemic damages from vasopressors, or toxicity 
of a local anesthetic, the possibility for neurological damages 
increases. However, Hebl et al. [7] argue that neurological 
damages after operation occur from the combination of 
various factors including the lifestyle of patients, damages 
during operation, pressure of the tourniquet, posture of the 
patients during operation, dystocia, and anesthesia methods, 
and for diseases with progressive neurological damages, 
neurologic symptoms can be worsened regardless of methods 
of anesthesia and operations. Moreover, they said there was no 
case in which new or worsened neurologic damages occurred 
among 136 patients who had diseases showing neurologic 
dysfunction and who underwent regional anesthesia and pain 
control. Also, they added that worsening neurologic symptoms 
after regional anesthesia is not as common as expected in the 
past, and the operation of regional anesthesia is not taboo at 
all. Some patients with diseases in the central nervous system 
reported the case of worsening neurological function when 
operating regional anesthesia [8]; however, there was none 
for worsening neurological function after regional anesthesia 
for patients with a lower motor neuron disease. Moreover, 
operating regional anesthesia for patients with spinal muscular 
atrophy has advantages in that it can avoid possible respiratory 
complications or unanticipated extension of muscle relaxation. 
Weston and DiFazio [9] reported the case that conducted 
epidural pain control during delivery for a patient with type III 
spinal muscular atrophy, and Buettner [10] reported the case 
that conducted Cesarean delivery with epidural anesthesia 
for a patient with type III spinal muscular atrophy. Also, there 
is a report about the case that conducted regional anesthesia 
without neurological damages for patients with lower motor 
nervous disease including amyotrophic lateral sclerosis 
[11]. Domestically, there has been no case report yet about 
regional anesthesia for patients with spinal muscular atrophy. 
Meanwhile, Choi et al. [12] conducted total intravenous 
anesthesia without muscle relaxants for patients with type II 
spinal muscular atrophy, while Hong et al. [13] did for patients 
with type III spinal muscular atrophy. Both cases were for head 
and neck surgeries, and it is considered that general anesthesia 
was conducted for children patients. Consequently, conducting 
regional anesthesia for patients with neurological damages is 
not an ultimate taboo, and it should be decided considering the 
risks and advantages by individual conditions of the patients. 
    When operating regional anesthesia for patients with spinal 
muscular atrophy, expiratory reserve volume falls if the 
block area is more than the T6 segment, and the following 
malfunction of coughing decreases the removing function of the 
bronchial secretion. In this regard, it is critical to manage the 
height of the nerve block area properly [14]. By controlling the 
dose of local anesthetic injected by placing an epidural catheter 
to operate regional anesthesia, respiratory complications that 
occur from excessive nervous sense blocks can be prevented, 
and the anesthesia time can be prolonged for an unexpected 
extension of the operation. Also, for some patients with 
spinal muscular atrophy who have accompanying spinal 
malformation or who had corrected spinal malformation by 
operating surgeries, the available space for regional anesthesia 
should be confirmed by a simple radiograph before operation. 
Technical difficulties can be discovered when operating 
regional anesthesia for patients who are suffering from scoliosis 
or had corrected it through surgeries, and, in this case, regional 
anesthesia can be operated by identifying intervertebral 
foramen by using C-arm or ultrasonography, or through the 
spinal lumbarsacral region or scaral foramen. Since the volume 
of cerebrospinal fluid is decreased for extreme scoliokyphosis, 
even a little amount of local anesthetia can block sensory nerve 
up to a higher segment. Accordingly, physicians should pay 
special attention. 
    In this case study, the patient complained of paralysis at 
the intercostal muscle and mild dyspnea. From arterial blood 
gas analysis, arterial oxygen pressure showed 74.6 mmHg, 
a little lower figure. Although it was not serious, the patient 
showed gradual paralysis at the sub-respiratory root. Therefore, 
it was considered that there is the risk of delayed recovery 
of respiratory function or respiratory complications from 
difficulties of expectorating bronchial secretion or sputum after 
general anesthesia. Against this backdrop, regional anesthesia S68 www.ekja.org
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was considered to be more beneficial, so operating epidural 
anesthesia was decided. There were no special opinions on 
onset time and intensity compared to normal people while 
clinical duration was increased to 12 hours. However, the 
increased clinical duration was within the range of the normal 
upper limit. The height of sensory nerve block of epidural 
anesthesia is controlled by the dural surface area, while the 
height of motor nerve block and clinical duration is controlled 
by posterior epidural fat volume [15]. The cause for extension 
of clinical duration for epidural anesthesia up to the normal 
upper limit in this case study is considered to be other factors 
than spinal muscular atrophy. Consequently, by operating 
epidural anesthesia to the patient expecting knee synovectomy, 
bronchial intubation by using skeleton muscle relaxants could 
be prevented, and since the athletic ability was recovered 
as good as before the operation, even after removing the 
epidural catheter, regional anesthesia was conducted without 
any neurological injuries. Accordingly, the authors consider 
epidural anesthesia as a good alternative for patients with spinal 
muscular atrophy expecting a limb surgery.
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